Australia Microfluidics Market Size & Outlook, 2026-2033
The microfluidics market in Australia is expected to reach a projected revenue of US$ 1,194.9 million by 2033. A compound annual growth rate of 9.7% is expected of Australia microfluidics market from 2026 to 2033.
In terms of revenue, Australia accounted for 1.4% of the global microfluidics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China microfluidics market is projected to lead the regional market in terms of revenue in 2033.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 9,937.6 million by 2033.
Over the past decade, the Australian microfluidics space has witnessed a paradigm shift in the applications and capabilities with regard to microfluidics technology. This is a rapidly growing field in Australia.
This can be attributed to the increasing adoption of microfluidic devices in clinics, increasing collaborative efforts between manufacturers, investors, and researchers, and expanding its applications in medical as well as nonmedical fields.
These companies implement various strategic initiatives to maintain their market position. SCHOTT MINIFAB collaborates with clients to offer contract manufacturing and product development services for diagnostics and life science microfluidics requirements.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Microfluidics Market Outlook will help companies and investors design strategic landscapes.
Microfluidic Components was the largest segment with a revenue share of 85.69% in 2025.
Horizon Databook has segmented the Australia microfluidics market based on microfluidic components, microfluidic-based devices covering the revenue growth of each sub-segment from 2021 to 2033.
Over the past decade, the Australian microfluidics space has witnessed a paradigm shift in the applications and capabilities with regard to microfluidics technology. This is a rapidly growing field in Australia.
This can be attributed to the increasing adoption of microfluidic devices in clinics, increasing collaborative efforts between manufacturers, investors, and researchers, and expanding its applications in medical as well as nonmedical fields.
These companies implement various strategic initiatives to maintain their market position. SCHOTT MINIFAB collaborates with clients to offer contract manufacturing and product development services for diagnostics and life science microfluidics requirements.
Australia Microfluidics Market Product Outlook (Revenue, USD Million , 2021-2033)
Microfluidic Components
Microfluidic-based Devices
Australia Microfluidics Market Technology Outlook (Revenue, USD Million , 2021-2033)
Lab-on-a-Chip
Continuous Flow Microfluidics
Electrophoresis and Microfluidics
Acoustofluidics and Microfluidics
Optofluidics and Microfluidics
Organ-on-a-Chip
Australia Microfluidics Market Material Type Outlook (Revenue, USD Million , 2021-2033)
PDMS
Glass
Polymer
Silicon
Others
Australia Microfluidics Market Application Outlook (Revenue, USD Million , 2021-2033)
Medical
Non-medical
Reasons to subscribe to Microfluidics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Microfluidics Market Outlook databook
Our clientele includes a mix of Microfluidics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Microfluidics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Microfluidics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.